Modern Setup Host Windows 10
Kroger Feedback


SDPA Summer 2017 Live Blog

SDPA Summer | Live Blog | Product Theater: Introducing a New Innovation in the Treatment of Persistent Facial Erythema

Sponsored by Allergan, Inc.

During Friday morning’s first product theater at the SDPA Annual Summer Dermatology Conference in San Diego, California, Dr. Julie Harper, an acne and rosacea specialist, shared her extensive knowledge and experience in the treatment of patients with persistent facial erythema. She recommended focusing on what we, as clinicians, see rather than focusing on the subtype of rosacea when developing a treatment plan for rosacea patients.

Dr. Harper discussed the physiology of chronic facial dilation resulting in persistent facial erythema. One approach to treat vasodilation involves the use of a topical vasoconstrictor, such as an alpha-adrenergic agonist such as oxymetazoline. Rhofade®, or oxymetazoline HCl 1% cream, is a once daily topical treatment indicated for persistent facial erythema associated with rosacea in adults. It is important that patients apply this product when they want their facial erythema most controlled, for example, in the morning.
When considering use of alpha-adrenergic agonists, clinicians must consider the way in which these agonists work systemically. Therefore, a patient’s cardiovascular health is important to consider when using an agent that may cause vasoconstriction. Rhofade® cream should be used with caution in patients with severe, unstable or uncontrolled cardiovascular disease, cerebral insufficiency, scleroderma, Raynaud’s syndrome and a history of narrow-angle glaucoma.

Dr. Harper also recommends avoiding application of Rhofade® 1% cream to the lips and periorbital rim area due to its vasoconstrictive properties.
Lastly, Rhofade® is a safe, well tolerated treatment that is FDA approved for persistent facial erythema that allows for the immediate improvement in erythema from day one for the majority of patients.


Byline: Sarah Patton, PA-C, MSHS

Posted: June 3, 2017

Key Words: Julie Harper, acne, rosacea, sdpa, society of dermatology physician assistants, summer conference, san diego

Our Sponsors